Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2021
Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for RecurrenceTanner M Johnson, Kyle C Molina, Amanda H Howard, et al.
BMC Infectious Diseases|January 24, 2024
Oritavancin as sequential therapy for Gram-positive bloodstream infectionsWilliams Monier Texidor, Matthew A Miller, Kyle C Molina, et al.
Open Forum Infectious Diseases|February 3, 2022
Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill PatientsAlison R Novak, Martin Krsak, Tyree H Kiser, et al.
Expert Opinion on Pharmacotherapy|April 21, 2021
An overview of current and emerging antifungal pharmacotherapy for invasive fungal infectionsScott W Mueller, Sonya K Kedzior, Matthew A Miller, et al.
Open Forum Infectious Diseases|May 26, 2022
Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical SuccessTaylor Morrisette, Kyle C Molina, Beatriz Da Silva, et al.
Open Forum Infectious Diseases|July 28, 2022
Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for <i>Staphylococcus aureus</i> Bloodstream InfectionsKyle C Molina, Cali Lunowa, Madelyn Lebin, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 14, 2023
Augmented Renal Function in Burn Patients: Occurrence and Discordance With Commonly Used Methods to Assess Renal FunctionScott W Mueller, Brittany Blass, Kyle C Molina, et al.
Military Medicine|March 12, 2026
The Evolving Frontline of Antimicrobial Resistance: Adapting Testing and Treatment for Austere and Combat SettingsKyle C Molina, Corey Bills, Vikhyat S Bebarta, et al.
Pharmacotherapy|November 12, 2025
Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta-Analysis of Observational StudiesMartin Krsak, David Klimpl, Scott W Mueller, et al.
Clinical Orthopaedics and Related Research|March 19, 2025
Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium?Martin Krsak, Taylor Morrisette, Laura Damioli, et al.
Pageof 6